The groundbreaking therapy of this peptide represents a exciting development in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide238194.vblogetin.com/48132238/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment